Case Report
Published on 19 Dec 2025
Case Report: Deep and durable response to talazoparib in germline BRCA2-mutated rectal neuroendocrine carcinoma
- 659 views
Case Report
Published on 19 Dec 2025
Case Report
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Review
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Review
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Original Research
Accepted on 18 Dec 2025
Case Report
Accepted on 18 Dec 2025
Case Report
Published on 18 Dec 2025
Systematic Review
Published on 18 Dec 2025
Mini Review
Published on 18 Dec 2025
Original Research
Published on 18 Dec 2025
Original Research
Published on 18 Dec 2025
Systematic Review
Published on 18 Dec 2025
Original Research
Published on 18 Dec 2025